A new baby-specific malaria drug and improved tests mark a breakthrough for newborn and infant treatment worldwide.

Ahead of World Malaria Day on 25 April, the World Health Organization (WHO) has announced a significant step forward in the ...

The World Health Organization announced Friday that it had given prequalification approval to a malaria treatment for ...

Swiss medical authorities have approved the first drug suitable to treat malaria in babies and very young children. Eight African countries that participated in clinical trials are now poised to ...

Add Yahoo as a preferred source to see more of our stories on Google. Spread largely by mosquitos, Malaria causes a fever, headaches, confusion and muscle pains among other symptoms and can be fatal.

Malaria is preventable, yet still kills children worldwide. Learn why progress can be reversed and how you can help protect ...

Novartis today announced that the World Health Organization (WHO) has prequalified Coartem® (artemether-lumefantrine) Baby, the first and only antimalarial developed specifically for newborns and ...

While malaria typically causes fever, chills, sweating, and body aches, cerebral malaria involves the central nervous system.

From monsoon-triggered fevers to life-threatening complications, Firstpost brings you expert insights on how malaria presents ...

Progress has not come from a single discovery, but from decades of incremental advances, each building on the last.